PTP1B-IN-22

CAS No. 86109-60-6

PTP1B-IN-22( —— )

Catalog No. M36056 CAS No. 86109-60-6

PTP1B-IN-22 is a protein tyrosine phosphatase 1B (PTP1B) inhibitor that inhibits glucose uptake in skeletal muscle L6 myotubes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 37 Get Quote
25MG 78 Get Quote
50MG 125 Get Quote
100MG 201 Get Quote
500MG 469 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PTP1B-IN-22
  • Note
    Research use only, not for human use.
  • Brief Description
    PTP1B-IN-22 is a protein tyrosine phosphatase 1B (PTP1B) inhibitor that inhibits glucose uptake in skeletal muscle L6 myotubes.
  • Description
    PTP1B-IN-22, a ZINC02765569 derivative, is a potent protein tyrosine phosphatase 1B (PTP1B) inhibitor. PTP1B-IN-22 has PTP1B inhibition and glucose uptake in skeletal muscle L6 myotubes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86109-60-6
  • Formula Weight
    344.41
  • Molecular Formula
    C16H12N2O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (290.35 mM; Ultrasonic )
  • SMILES
    OC(=O)c1ccc(NC(=O)CSc2nc3ccccc3s2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Prashant J, et, al. Molecular modeling and synthesis of ZINC02765569 derivatives as protein tyrosine phosphatase 1B inhibitors: lead optimization study. 2012;22: 1618-23.
molnova catalog
related products
  • Ergosterol

    Ergosterol is a steroid extracted from Ganoderma lucidum cystocarp.

  • SHP099 monohydrochlo...

    SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.

  • Managlinat dialaneti...

    Managlinat dialanetil (MB06322) is an orally available and potent fructose 1,6-bisphosphatase (FBPase) inhibitor with hypoglycaemic activity for the study of type 2 diabetes.